About
Oonagh Shannon is an affiliated researcher with a PhD and the academic title of Reader in Experimental Infection Medicine at Lund University. She is part of the Infection Medicine Proteomics group, focusing on interdisciplinary research connecting Medical and Health Sciences, Microbiology, and Immunology. Her work addresses critical health challenges including Sepsis, Platelet Immunology, and Streptococcus infections with proteomic and molecular approaches.
Her research interests span:
- Sepsis – investigating extracellular vesicles and immune responses
- Platelet Activation – studying thrombocytopenia and inflammatory processes
- Antibody Engineering – enhancing Fc-mediated functions against pathogens
- Biofilm Dispersal – analyzing bacterial virulence mechanisms
- Proteomic Analysis – mapping immune interactions with pathogens
Recent publications highlight her contributions to Proteomics and Infection Medicine:
- 2025: Proteomic profiling in murine bacterial sepsis
- 2024: Mechanisms of thrombocytopenia during infections
- 2024: Hybrid IgG subclasses for SARS-CoV-2 and streptococcal antibodies
- 2024: Leukocyte activation by biofilm-dispersed bacteria
- 2024: Quantifying immune responses to streptococcal M1 protein
Notable scientific awards include:
- Minerva Leadership (2021) – recognizing her leadership in infection proteomics
- Flormanska Prize (2014) – for achievements in medical research
- Schybergs Scholarship (2013) – supporting her early career
She has supervised multiple PhD projects, including studies on:
- Endocarditis caused by Streptococcus bovis
- Cystic Fibrosis airway infections
- Protective antibody responses against bacterial pathogens
- Platelet profiling in COVID-19 progression
Oonagh Shannon collaborates with the Science for Life Laboratory (SciLifeLab) and international institutions, applying Proteomics and Immunology to address UN Sustainable Development Goals related to health and well-being.
